CNS Pharmaceuticals Inc.

0.10
-0.00 (-3.47%)
At close: Jan 29, 2025, 3:59 PM
0.10
0.00%
After-hours Jan 29, 2025, 07:58 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Cash & Equivalents 548.72K 10.06M 5.00M 14.04M 7.24M 282.74K 110.54K
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 104.75K 482.81K 1.26M 334.14K -0.00 95.20K n/a
Receivables n/a n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 1.04M 5.02M 2.47M 1.46M 652.62K 305.40K 51.65K
Total Current Assets 1.59M 12.56M 7.48M 15.50M 7.89M 588.13K 162.19K
Property-Plant & Equipment 4.93K 5.66K 16.11K 23.43K 18.16K n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 109.68K 488.47K 1.28M 357.57K 18.16K 95.20K n/a
Total Assets 1.70M 13.05M 8.76M 15.85M 7.91M 683.33K 162.19K
Account Payables 5.83M 3.68M 1.98M 946.33K 289.50K 128.87K 57.50K
Deferred Revenue n/a n/a n/a n/a n/a 23.60K n/a
Short-Term Debt 300.81K 409.97K 387.79K 439.29K n/a 316.92K 121.83K
Other Current Liabilities n/a 828.39K 224.95K 519.80K 21.50K 786.85K 41.40K
Total Current Liabilities 6.13M 4.92M 2.14M 1.91M 311.00K 1.23M 220.73K
Long-Term Debt n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities n/a 4.09M n/a n/a n/a 445.78K 179.32K
Total Liabilities 6.13M 4.92M 2.14M 1.91M 311.00K 1.23M 220.73K
Total Debt 300.81K 409.97K 387.79K 439.29K n/a 316.92K 121.83K
Common Stock 6.21K 1.62K 27.93K 23.86K 16.45K 12.70K 10.27K
Retained Earnings -69.57M -50.72M -34.98M -20.95M -11.49M -7.61M -219.36K
Comprehensive Income n/a n/a n/a -0.00 -0.00 n/a n/a
Shareholders Equity -4.43M 8.13M 6.62M 13.95M 7.60M -549.30K -58.53K
Total Investments n/a n/a n/a n/a n/a n/a n/a

Create Price Alert on CNSP

Your price alert will notify you when the stock price is above 0.10.

Add to Watchlist